Olivier Corbeil, Sébastien Brodeur, Josiane Courteau, Laurent Béchard, Maxime Huot-Lavoie, Elaine Angelopoulos, Samanta Di Stefano, Erica Marrone, Alain Vanasse, Marie-Josée Fleury, Emmanuel Stip, Alain Lesage, Ridha Joober, Marie-France Demers, Marc-André Roy
BACKGROUND: Although attention-deficit hyperactivity disorder (ADHD) is often comorbid with schizophrenia spectrum and other psychotic disorders (SZSPD), concerns about an increased risk of psychotic events have limited its treatment with either psychostimulants or atomoxetine. AIMS: To examine whether the risk of hospital admission for psychosis in people with SZSPD was increased during the year following the introduction of such medications compared with the year before...
March 2024: British Journal of Psychiatry